Counseling About Genetic Testing and Communication of Genetic Test Results

Obstetrics and Gynecology

Volumn 129, Issue 4, 2017, Pages E96-E101

  Biggio, Joseph R ^a   Ralston, Steven J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; COMMUNICATION SKILL; COMPREHENSION; ELECTRONIC HEALTH RECORD; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GYNECOLOGIST; HEALTH CARE PERSONNEL; HUMAN; MEDICAL PRACTICE; OBSTETRICIAN; PATIENT COUNSELING; PATIENT DECISION MAKING; PREDICTIVE VALUE; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TIME TO TREATMENT; DECISION MAKING; DOCTOR PATIENT RELATION; ETHICS; GYNECOLOGY; INTERPERSONAL COMMUNICATION; OBSTETRICS; ORGANIZATION AND MANAGEMENT; PREPREGNANCY CARE; PROCEDURES; PSYCHOLOGY; STANDARDS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

DECISION MAKING; DISCLOSURE; FEMALE; GENETIC COUNSELING; GENETIC TESTING; GYNECOLOGY; HUMANS; OBSTETRICS; PHYSICIAN-PATIENT RELATIONS; PRECONCEPTION CARE; QUALITY IMPROVEMENT; RISK ASSESSMENT; UNITED STATES;

EID: 85021854282     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000002020     Document Type: Article

References (15)

1. Hudson K, Javitt G, Burke W, Byers P. ASHG statement on direct-to-consumer genetic testing in the United States. American Society of Human Genetics Social Issues Committee. Obstet Gynecol 2007;110:1392–5. [PubMed] [Obstetrics & Gynecology]
2. van der Wouden CH, Carere DA, Maitland-van der Zee AH, Ruffin MT 4th, Roberts JS, Green RC, et al. Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Ann Intern Med 2016;164:513–22.[PubMed] [Full Text]
3. Karlan BY, Berchuck A, Mutch D. The role of genetic testing for cancer susceptibility in gynecologic practice. Obstet Gynecol 2007;110:155–67. [PubMed] [Obstetrics & Gynecology]
4. Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep 2013;30:1019–29. [PubMed] [Full Text]
5. Screening for fetal aneuploidy. Practice Bulletin No. 163. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e123–37. [PubMed] [Obstetrics & Gynecology]
6. Klein RD, Mahoney MJ. Medical legal issues in prenatal diagnosis. Clin Perinatol 2007;34:287–97, vi. [PubMed]
7. Pergament D, Ilijic K. The legal past, present and future of prenatal genetic testing: professional liability and other legal challenges affecting patient access to services. J Clin Med 2014;3:1437–65. [PubMed] [Full Text]
8. Offit K, Thom P. Ethical and legal aspects of cancer genetic testing. Semin Oncol 2007;34:435–43. [PubMed]
9. Marchant GE, Lindor RA. Personalized medicine and genetic malpractice. Genet Med 2013;15:921–2. [PubMed] [Full Text]
10. Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015; 125:1538–43. [PubMed] [Obstetrics & Gynecology]
11. Green RC, Lautenbach D, McGuire AL. GINA, genetic discrimination, and genomic medicine. N Engl J Med 2015; 372:397–9. [PubMed] [Full Text]
12. Voracek M, Haubner T, Fisher ML. Recent decline in nonpaternity rates: a cross-temporal meta-analysis. Psychol Rep 2008;103:799–811. [PubMed]
13. Tracking and reminder systems. Committee Opinion No. 546. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:1535–7. [PubMed] [Obstetrics & Gynecology]
14. Offit K, Groeger E, Turner S, Wadsworth EA, Weiser MA. The “duty to warn” a patient’s family members about hereditary disease risks. JAMA 2004;292:1469–73. [PubMed]
15. Ethical issues in genetic testing. ACOG Committee Opinion No. 410. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;111:1495–502. [PubMed] [Obstetrics & Gynecology]